Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells - PubMed (original) (raw)

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

H Groux et al. J Exp Med. 1996.

Abstract

Human CD4+ T cells, activated by allogeneic monocytes in a primary mixed lymphocyte reaction in the presence of exogenous interleukin (IL) 10, specifically failed to proliferate after restimulation with the same alloantigens. A comparable state of T cell unresponsiveness could be induced by activation of CD4+ T cells by cross-linked anti-CD3 monoclonal antibodies (mAbs) in the presence of exogenous IL-10. The anergic T cells failed to produce IL-2, IL-5, IL-10, interferon gamma, tumor necrosis factor alpha, and granulocyte/macrophage colony-stimulating factor. The IL-10-induced anergic state was long-lasting. T cell anergy could not be reversed after restimulation of the cells with anti-CD3 and anti-CD28 mAbs, although CD3 and CD28 expression was normal. In addition, restimulation of anergized T cells with anti-CD3 mAbs induced normal Ca2+ fluxes and resulted in increased CD3, CD28, and class II major histocompatibility complex expression, indicating that calcineurin-mediated signaling occurs in these anergic cells. However, the expression of the IL-2 receptor alpha chain was not upregulated, which may account for the failure of exogenous IL-2 to reverse the anergic state. Interestingly, anergic T cells and their nonanergic counterparts showed comparable levels of proliferation and cytokine production after activation with phorbol myristate acetate and Ca2+ ionophore, indicating that a direct activation of a protein kinase C-dependent pathway can overcome the tolerizing effect of IL-10. Taken together, these data demonstrate that IL-10 induces T cell anergy and therefore may play an important role in the induction and maintenance of antigen-specific T cell tolerance.

PubMed Disclaimer

Comment in

Similar articles

Cited by

References

    1. J Exp Med. 1991 Oct 1;174(4):915-24 - PubMed
    1. J Immunol. 1991 Nov 15;147(10):3261-7 - PubMed
    1. Immunol Today. 1992 Feb;13(2):69-73 - PubMed
    1. J Immunol. 1992 May 15;148(10):3133-9 - PubMed
    1. Science. 1992 Aug 7;257(5071):792-5 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources